Search Clinical Trials
589,279 trials
ID
Status
Phase
Title
Sponsor
NCT07647146
Corneal Epithelial Thickness Mapping by Anterior Segment Optical Coherence Tomography in Patients With Refractive ErrorsSohag UniversityNot Yet Recruiting
NCT07647146Not Yet Recruiting
—
Corneal Epithelial Thickness Mapping by Anterior Segment Optical Coherence Tomog...Sohag University
NCT07647796
Infection Prevention for "Bellwether" Surgery in EthiopiaKarolinska InstitutetNot Yet Recruiting
NCT07647796Not Yet Recruiting
—
Infection Prevention for "Bellwether" Surgery in EthiopiaKarolinska Institutet
NCT07646951
Aquatic Therapy Versus Sensory Room Intervention for Sensory-Motor Function in Children With Sensory Processing DisorderMTI UniversityNot Yet RecruitingNot Applicable
NCT07646951Not Yet Recruiting
Not Applicable
Aquatic Therapy Versus Sensory Room Intervention for Sensory-Motor Function in C...MTI University
NCT07647289
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBCJiangsu Provincial People's HospitalRecruitingPhase 2
NCT07647289Recruiting
Phase 2
EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBCJiangsu Provincial People...
NCT07648875
Water Vapor Thermal Therapy Versus Ejaculation-Preserving HoLEP for Benign Prostatic HyperplasiaBeni-Suef UniversityRecruitingNot Applicable
NCT07648875Recruiting
Not Applicable
Water Vapor Thermal Therapy Versus Ejaculation-Preserving HoLEP for Benign Prost...Beni-Suef University
NCT07648472
A Study of the Safety and Efficacy of the Intravenous and Intratumoral Injection of OVV-01 in Patients With Advanced Solid Tumours.Cancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingPhase 1
NCT07648472Recruiting
Phase 1
A Study of the Safety and Efficacy of the Intravenous and Intratumoral Injection...Cancer Institute and Hosp...
NCT07648901
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain InjuryBaylor Research InstituteNot Yet Recruiting
NCT07648901Not Yet Recruiting
—
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity...Baylor Research Institute
NCT07647848
Therapy Adjustment and IndividuaLized Response With Biomarker Observation in ReaL-world Heart FailureCharite University, Berlin, GermanyNot Yet Recruiting
NCT07647848Not Yet Recruiting
—
Therapy Adjustment and IndividuaLized Response With Biomarker Observation in Rea...Charite University, Berli...
NCT07647068
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal TumorsJoal BeaneNot Yet RecruitingPhase 2
NCT07647068Not Yet Recruiting
Phase 2
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment o...Joal Beane
NCT07648992
Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell TransplantationDaihong LiuRecruitingPhase 4
NCT07648992Recruiting
Phase 4
Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hem...Daihong Liu
NCT07648316
Effects of Red Panax Ginseng Supplementation on Cognitive Performance and Emotional Well-Being in Young Healthy AdultsArizona State UniversityNot Yet RecruitingNot Applicable
NCT07648316Not Yet Recruiting
Not Applicable
Effects of Red Panax Ginseng Supplementation on Cognitive Performance and Emotio...Arizona State University
NCT07646912
Effect of High-Intensity Focused Electromagnetic Therapy on Balance and Quality of Life in Patients With Multiple SclerosisMiddle East UniversityNot Yet RecruitingNot Applicable
NCT07646912Not Yet Recruiting
Not Applicable
Effect of High-Intensity Focused Electromagnetic Therapy on Balance and Quality...Middle East University
NCT07647263
Trastuzumab Rezetecan Neoadjuvant Therapy in THP-Insensitive HER2-Positive Early Breast CancerThe First Affiliated Hospital of Soochow UniversityRecruitingPhase 2
NCT07647263Recruiting
Phase 2
Trastuzumab Rezetecan Neoadjuvant Therapy in THP-Insensitive HER2-Positive Early...The First Affiliated Hosp...
NCT07646821
A Phase 1b/2 Study of Ropeginterferon Alfa-2b Added to Azacitidine in Newly Diagnosed MDS/AML (≥ 10% Blasts) With TP53 MutationsM.D. Anderson Cancer CenterNot Yet RecruitingPhase 1
NCT07646821Not Yet Recruiting
Phase 1
A Phase 1b/2 Study of Ropeginterferon Alfa-2b Added to Azacitidine in Newly Diag...M.D. Anderson Cancer Cent...
NCT07647328
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast CancerAstraZenecaNot Yet RecruitingPhase 3
NCT07647328Not Yet Recruiting
Phase 3
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2...AstraZeneca
NCT07648836
Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic ArthritisAssiut UniversityNot Yet Recruiting
NCT07648836Not Yet Recruiting
—
Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psor...Assiut University
NCT07646652
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body DiseaseStanford UniversityNot Yet Recruiting
NCT07646652Not Yet Recruiting
—
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Sym...Stanford University
NCT07648693
Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET TrialResonova (Shanghai) Medtech LimitedRecruitingNot Applicable
NCT07648693Recruiting
Not Applicable
Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System...Resonova (Shanghai) Medte...
NCT07647523
Determining the Effect of Home BLOOD Glucose Monitoring on HBA1C in Patients With Type 2 Diabetes Using Smartphone ApplicationDokuz Eylul UniversityCompletedNot Applicable
NCT07647523Completed
Not Applicable
Determining the Effect of Home BLOOD Glucose Monitoring on HBA1C in Patients Wit...Dokuz Eylul University
Result Breakdown
Not yet recruiting12 (60%)
Recruiting7 (35%)
Completed1 (5%)
Not Specified7 (35%)
not_applicable6 (30%)
Phase 23 (15%)
Phase 12 (10%)
Phase 41 (5%)
Phase 31 (5%)